Morgan Stanley Resumes Coverage of Covidien (COV), Baxter (BAX), Becton Dickinson (BDX), Hospira (HSP), Integra (IART)
More News related to BAX
- David Moenning's Daily State of the Markets: 11/24
- Relational Investors Raises Stakes In Yahoo! (YHOO) and Sun Microsystems (JAVA), Shows New Stake In Schering-Plough (SGP)
- Baxter International (BAX) Boosts Qt Dividend 20% to $0.26/Sh
- Baxter Declares Quarterly Dividend, Increases Rate 20 Percent
- AmeriCares Launches India Operations
More News related to BDX
- Becton Dickinson (BDX) Announces 10M Share Buyback
- Becton, Dickinson and Company (BDX) Boosts Qtr. Dividend by 15.8% to $0.33/Share
- BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
- Becton, Dickinson (BDX) Tops Q3 Views; Names New President and New CFO
- BD Announces Executive Appointments of President and Chief Financial Officer
More News related to COV
- Covidien's Hi-Lo Evac(TM) Endotracheal Tube Selected for Premier QUEST Comparative Innovation Program
- Covidien (COV) and Depomed (DEPO) Announce License Agreement
- Covidien and Depomed Announce License Agreement
- Covidien Launches Improved Magellan Safety Hypodermic Needle
- Citi Maintains 'Buy' on Covidien Ltd (COV), Lowers Price Target
More News related to New Coverage
- Raymond James Starts Millicom (MICC) at Strong Buy
- Stifel Nicolaus Starts City National (CYN) at Hold
- Stifel Nicolaus Starts eHealth (Nasdaq: HLTH) with a Buy
- Wasserman & Associates initiates coverage on American Physicians Service Group (AMPH) with a Buy
- Jesup & Lamont Initiates Coverage on AutoZone (AZO) with a Hold.
After the close today, Morgan Stanley resumed coverage of several stocks in the Healthcare sector:
with an Overweight rating:
with an Underweight rating:
- Integra LifeSciences (Nasdaq: IART)
Related Categories
New CoverageStocks Mentioned
+0.57Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
